ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer

271Citations
Citations of this article
211Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The non-invasive photodynamic therapy has been limited to treat superficial tumours, primarily ascribed to poor tissue penetration of light as the energy source. Herein, we designed a long-circulating hydrophilized titanium dioxide nanoparticle (HTiO2 NP) that can be activated by ultrasound to generate reactive oxygen species (ROS). When administered systemically to mice, HTiO2 NPs effectively suppressed the growth of superficial tumours after ultrasound treatments. In tumour tissue, the levels of proinflammatory cytokines were elevated several fold and intense vascular damage was observed. Notably, ultrasound treatments with HTiO2 NPs also suppressed the growth of deeply located liver tumours at least 15-fold, compared to animals without ultrasound treatments. This study provides the first demonstration of the feasibility of using HTiO2 NPs as sensitizers for sonodynamic therapy in vivo.

Cite

CITATION STYLE

APA

You, D. G., Deepagan, V. G., Um, W., Jeon, S., Son, S., Chang, H., … Park, J. H. (2016). ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer. Scientific Reports, 6. https://doi.org/10.1038/srep23200

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free